The goal of this study was to validate the previously observed high biological kill performance of the PAEROSOL decontamination technology against common HAIs in a non-human subject trial within a hospital setting of Madigan Army Medical Center (MAMC) on Joint Base Lewis-McChord in Tacoma, Washington.